Discovering Statistics Using IBM SPSS Statistics

With an exciting new look, math diagnostic tool, and a research roadmap to navigate projects, this new edition of Andy Field’s award-winning text offers a unique combination of humor and step-by-step instruction to make learning statistics compelling and accessible to even the most anxious of students. 

https://amzn.to/3429Rhv

The Fifth Edition takes students from initial theory to regression, factor analysis, and multilevel modeling, fully incorporating IBM SPSS Statistics© version 25 and fascinating examples throughout.

Statistical methods are a key part of data science, yet very few data scientists have any formal statistics training. Courses and books on basic statistics rarely cover the topic from a data science perspective. This practical guide explains how to apply various statistical methods to data science, tells you how to avoid their misuse, and gives you advice on what's important and what's not.

Many data science resources incorporate statistical methods but lack a deeper statistical perspective. If you’re familiar with the R programming language, and have some exposure to statistics, this quick reference bridges the gap in an accessible, readable format.

With this book, you’ll learn: https://amzn.to/3429Rhv

• Why exploratory data analysis is a key preliminary step in data science
• How random sampling can reduce bias and yield a higher quality dataset, even with big data
• How the principles of experimental design yield definitive answers to questions
• How to use regression to estimate outcomes and detect anomalies
• Key classification techniques for predicting which categories a record belongs to
• Statistical machine learning methods that “learn” from data
• Unsupervised learning methods for extracting meaning from unlabeled data.

Beautiful Swan

Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials (materials whose structure is on the scale of nanometers, i.e. billionths of a meter).


A ribosome is a biological machine.
Functionalities can be added to nanomaterials by interfacing them with biological molecules or structures. The size of nanomaterials is similar to that of most biological molecules and structures; therefore, nanomaterials can be useful for both in vivo and in vitro biomedical research and applications. Thus far, the integration of nanomaterials with biology has led to the development of diagnostic devices, contrast agents, analytical tools, physical therapy applications, and drug delivery vehicles.

Nanomedicine seeks to deliver a valuable set of research tools and clinically useful devices in the near future. The National Nanotechnology Initiative expects new commercial applications in the pharmaceutical industry that may include advanced drug delivery systems, new therapies, and in vivo imaging. Nanomedicine research is receiving funding from the US National Institutes of Health Common Fund program, supporting four nanomedicine development centers.

Nanomedicine sales reached $16 billion in 2015, with a minimum of $3.8 billion in nanotechnology R&D being invested every year. Global funding for emerging nanotechnology increased by 45% per year in recent years, with product sales exceeding $1 trillion in 2013. As the nanomedicine industry continues to grow, it is expected to have a significant impact on the economy.